These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24686171)

  • 1. Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression.
    Wallington-Beddoe CT; Powell JA; Tong D; Pitson SM; Bradstock KF; Bendall LJ
    Cancer Res; 2014 May; 74(10):2803-15. PubMed ID: 24686171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
    Venkata JK; An N; Stuart R; Costa LJ; Cai H; Coker W; Song JH; Gibbs K; Matson T; Garrett-Mayer E; Wan Z; Ogretmen B; Smith C; Kang Y
    Blood; 2014 Sep; 124(12):1915-25. PubMed ID: 25122609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.
    Lewis CS; Voelkel-Johnson C; Smith CD
    Oncotarget; 2016 Sep; 7(37):60181-60192. PubMed ID: 27517489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
    Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
    Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.
    Schrecengost RS; Keller SN; Schiewer MJ; Knudsen KE; Smith CD
    Mol Cancer Res; 2015 Dec; 13(12):1591-601. PubMed ID: 26271487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.
    Vilas-Zornoza A; Agirre X; Abizanda G; Moreno C; Segura V; De Martino Rodriguez A; José-Eneriz ES; Miranda E; Martín-Subero JI; Garate L; Blanco-Prieto MJ; García de Jalón JA; Rio P; Rifón J; Cigudosa JC; Martinez-Climent JA; Román-Gómez J; Calasanz MJ; Ribera JM; Prósper F
    Leukemia; 2012 Jul; 26(7):1517-26. PubMed ID: 22307227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MYC protein and proteins antigenically related with MYC in acute lymphoblastic leukemia].
    Miranda Peralta EI; Valles Ayoub Y; Hernández Mendoza L; Rangel Ramírez LM; Castrejón Rojas A; Collazo-Jaloma J; Gutiérrez Romero M; González Constance R; Gariglio Vidal P
    Rev Invest Clin; 1991; 43(2):139-45. PubMed ID: 1947468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response.
    Dixon ZA; Nicholson L; Zeppetzauer M; Matheson E; Sinclair P; Harrison CJ; Irving JA
    Haematologica; 2017 Apr; 102(4):736-745. PubMed ID: 27979926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of bcl-2, c-myc genes and their relationship in patients with acute leukemia].
    Chen SP; Tang GC
    Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):83-5. PubMed ID: 12536628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Koeffler HP; Yokoyama A
    Leukemia; 2008 Dec; 22(12):2159-68. PubMed ID: 18784743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia.
    Folgiero V; Sorino C; Pallocca M; De Nicola F; Goeman F; Bertaina V; Strocchio L; Romania P; Pitisci A; Iezzi S; Catena V; Bruno T; Strimpakos G; Passananti C; Mattei E; Blandino G; Locatelli F; Fanciulli M
    EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29367285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
    Horiguchi-Yamada J; Fukumi S; Saito S; Nakayama R; Iwase S; Yamada H
    Anticancer Res; 2002; 22(6C):3827-32. PubMed ID: 12553001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
    Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
    Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
    Mao B; Zhao G; Lv X; Chen HZ; Xue Z; Yang B; Liu DP; Liang CC
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1573-81. PubMed ID: 21807113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-MYC overexpression overrides TAK1 dependency in efficient tumorigenicity of AKT-transformed cells.
    Qu Y; Zhang L; Ma A; Zhang F; Li J; Xu D; Yang Z; Qin W; Liu Y
    Cancer Lett; 2013 Aug; 336(2):290-8. PubMed ID: 23523871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer.
    Camarero N; Mascaró C; Mayordomo C; Vilardell F; Haro D; Marrero PF
    Mol Cancer Res; 2006 Sep; 4(9):645-53. PubMed ID: 16940161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc.
    Mata-Greenwood E; Cuendet M; Sher D; Gustin D; Stock W; Pezzuto JM
    Leukemia; 2002 Nov; 16(11):2275-84. PubMed ID: 12399973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
    Ho JS; Ma W; Mao DY; Benchimol S
    Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia.
    Suo S; Zhao D; Li F; Zhang Y; Rodriguez-Rodriguez S; Nguyen LXT; Ghoda L; Carlesso N; Marcucci G; Zhang B; Jin J
    Blood; 2024 Sep; 144(12):1343-1347. PubMed ID: 38968151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.